Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05765227 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens

A NA study of Refractive Ametropia, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT05765227 is a NA study of Refractive Ametropia that has completed, run by Alcon Research. The registered enrollment target is 18 participants, below the 231-participant average among 5 other Refractive Ametropia trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05765227, a NA study of Refractive Ametropia, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial was to evaluate the clinical performance of a manufacturing process on a frequent replacement multifocal contact lens.

Conditions Studied

Interventions

  • DEVICE Lehfilcon A multifocal contact lenses
  • DEVICE Lotrafilcon B multifocal contact lenses
  • DEVICE Hydrogen peroxide-based cleaning and disinfection system

Study Locations (1)

Georgia

  • Johns Creek Research Clinic - Johns Creek

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2023-03-08
Est. Completion 2023-03-30
Phase NA

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT05765227

The ClinicalTrials.gov registry entry for NCT05765227 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 231-participant average among 5 other Refractive Ametropia trials with a reported enrollment target (92% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Refractive Ametropia appearing as the primary indexed condition, and to 3 interventions - of which Lehfilcon A multifocal contact lenses is the first listed.

NCT05765227 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05765227 about?

NCT05765227 is a clinical study titled "Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens". The purpose of this clinical trial was to evaluate the clinical performance of a manufacturing process on a frequent replacement multifocal contact lens.

What is the current status of trial NCT05765227?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2023-03-08. Estimated completion is 2023-03-30.

What conditions does trial NCT05765227 study?

This clinical trial studies the following conditions: Refractive Ametropia.

What interventions are being tested in trial NCT05765227?

The interventions under investigation include: Lehfilcon A multifocal contact lenses (DEVICE), Lotrafilcon B multifocal contact lenses (DEVICE), Hydrogen peroxide-based cleaning and disinfection system (DEVICE).

Who is sponsoring clinical trial NCT05765227?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05765227 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Refractive Ametropia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.